Sign Out
The following undesirable effects have been observed during placebo-controlled clinical trials (n=2344) and post-marketing with the frequencies indicated as follows: See table.
Click on icon to see table/diagram/imageReporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is very important. It allows continued monitoring of the benefit/risk ratio of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions to the Drug Office, Department of Health.Website: http://www.drugoffice.gov.hk/eps/do/en/healthcare_providers/adr_reporting/index.html
View ADR Reporting Link
Continue with Google